These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7556338)

  • 21. [Is it possible to prevent kidney problems caused by immunosuppression?].
    Aitio ML
    Duodecim; 2000; 116(5):511-9. PubMed ID: 11787104
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients.
    Notaro E; Brown L; Albers E; Law S; Kemna M
    J Heart Lung Transplant; 2014 Jul; 33(7):766-8. PubMed ID: 24854566
    [No Abstract]   [Full Text] [Related]  

  • 23. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
    Chapman JR; Nankivell BJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
    [No Abstract]   [Full Text] [Related]  

  • 24. Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
    Mayer DF; Kushwaha SS
    Curr Opin Rheumatol; 2003 May; 15(3):219-25. PubMed ID: 12707574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extremely high serum level of IgE during immunosuppressive therapy: paradoxical effect of cyclosporine A and tacrolimus.
    Kawamura N; Furuta H; Tame A; Kobayashi I; Ariga T; Okano M; Sakiyama Y
    Int Arch Allergy Immunol; 1997 Apr; 112(4):422-4. PubMed ID: 9104801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

  • 27. [New developments in immunosuppressive therapy].
    Hopt UT
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():620-3. PubMed ID: 11824327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
    Lye WC
    Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and molecular aspects of autoimmune enteropathy and immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked syndrome.
    Ruemmele FM; Moes N; de Serre NP; Rieux-Laucat F; Goulet O
    Curr Opin Gastroenterol; 2008 Nov; 24(6):742-8. PubMed ID: 19122524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial.
    Yang HC; Holman MJ; Langhoff E; Ulsh PJ; Dellock CA; Gupta M; Ahsan N
    Transplant Proc; 1999; 31(1-2):1121-4. PubMed ID: 10083501
    [No Abstract]   [Full Text] [Related]  

  • 32. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 33. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lip hypertrophy due to cyclosporine therapy.
    Kapoor K; Saha A; Dubey NK
    Clin Exp Nephrol; 2014 Feb; 18(1):168-9. PubMed ID: 23615783
    [No Abstract]   [Full Text] [Related]  

  • 35. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F;
    Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract]   [Full Text] [Related]  

  • 36. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cyclosporin A and tacrolimus on sister chromatid exchange frequency in renal transplant patients.
    Oztürk S; Ayna TK; Cefle K; Palanduz S; Ciftçi HS; Kaya SA; Diler AS; Türkmen A; Gürtekin M; Sever MS; Carin M
    Genet Test; 2008 Sep; 12(3):427-30. PubMed ID: 18752452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
    Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
    Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of tacrolimus in 50 liver transplantation patients.
    Ye QF; Ruzig MA; Gong NQ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
    Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.